bpc-157 safety clinical data 🧵a few months ago i started looking at bpc-157. my research showed me that while there is very little evidence to show it works, there's even less to show it's safe BPC-157: Experimental Peptide Creates Risk

Each batch carefully lab tested after production (you can find Certificate of Analysis under product pictures)

and reported that in CD patients in sustained steroid-free remission undergoing combination therapy with infliximab and an immunomodulating drug, the withdrawal of infliximab should only be considered after a careful assessment of the risks and benefits for the individual patient, whereas the withdrawal of the immunomodulatory drug could generally represent the preferred strategy [93]

[48:52] I know there are a lot of patients with bendy conditions who have movement disorders like I'm sorry, not dysautonomia, dystonia

When NGF levels drop due to aging or chronic stress, we experience slower learning, poor memory recall, and a general sense of mental rigidity